Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 21, Issue 2, Pages 321-329
Publisher
Wiley
Online
2018-12-06
DOI
10.1111/dom.13607
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study
- (2018) Philip Home et al. DIABETES OBESITY & METABOLISM
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
- (2018) Alan J. Garber et al. Endocrine Practice
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin
- (2016) Denis Raccah et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Predictors of HbA1c over 4 years in people with type 2 diabetes starting insulin therapies: The CREDIT study
- (2015) Beverley Balkau et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD
- (2015) Lisa S. Chow et al. DIABETOLOGIA
- Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes
- (2015) Shi-Dou Lin et al. Primary Care Diabetes
- Predictive and Explanatory Factors of Change in HbA1cin a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs
- (2014) Philip D. Home et al. DIABETES CARE
- Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial
- (2014) DIABETES CARE
- Predictors of achieving HbA1c
- (2013) Paul Valensi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Clinical predictors of risk of hypoglycaemia during addition and titration of insulin glargine for type 2 diabetes mellitus
- (2013) D. M. Karl et al. DIABETES OBESITY & METABOLISM
- Assessing achievement and maintenance of glycemic control by patients initiating basal insulin
- (2012) Ning Wu et al. CURRENT MEDICAL RESEARCH AND OPINION
- Glycemic Response and Attainment of A1C Goals Following Newly Initiated Insulin Therapy for Type 2 Diabetes
- (2012) G. A. Nichols et al. DIABETES CARE
- The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
- (2012) K. Khunti et al. DIABETES OBESITY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started